Drug Metabolism Flashcards

1
Q

Drug metabolism

A

is the chemical transformation of a drug into one or more products within the body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Drug metabolism does

A
  • not occur for all drugs (like lithium)
  • protect the body against xenobiotics (e.g., drugs, toxins) - liver (primary) and other organs/tissues
  • first-pass (pre-systemic) metabolism (gut wall & liver)- ↓ bioavailability of orally administered drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Drug metabolism is mediated by what and involves what reactions

A

enzymes

oxidation, reduction,
hydrolysis and/or conjugation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

drug metabolising enzymes (DMEs)

A
  • Rich in liver
  • On membrane of ER of hepatocytes (liver cell like CYP450)
  • In cytosol (AD) or mitochondria (AldD) and other tissues/organs like the brain, lungs, plasma and intestines
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

First pass

A

the substance degradation of an orally administered drug caused by enzyme metabolism in the liver before the drug reaches the systemic circulation. It decrease the bioavailability administered of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Phase 1 Metabolism

A

Oxidation, reduction, hydrolysis
Parent drug (P1) metabolites (P2) conjugated metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

conjugated metabolites

A

virtually always inactive, very polar and/or ionized, and easily excreted.

(products of Phase II reactions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Phase 1 metabolism ethanol example

A

Ethanol (CH3CH2OH)

ADH (Alcohol Dehydrogenase) - removes H from parent drug

Forms: Acetaldehyde (CH3CH2O)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Phase 1 metabolism tenofovir disoproxil example hydrolysis

A
  • hydrolysis ester and (less readily) amide bonds
  • prodrug - a useful strategy to ↑ oral drug delivery
    • molecules with little or no pharmacological activity
      that are converted in vivo to active drugs

[Tenofovir Disoproxil

esterase

Tenofovir - not active and needs phosphorylation]

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Phase 2 metabolic reactions

A
  • Glucuronidation (UGT)
  • Sulfation (SULT)
  • Glutathione conjugation (GST)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Phase 2 metabolism

A

Conjugation reactions in which a polar molecule is linked to a suitable functional group on a drug or one of its Phase 1 metabolites

attach a polar endogenous molecule to a functional group in a drug - ↑ hydrophilicity to facilitate excretion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Glucuronidation

A

UGT (UDP glucuronosyltransferase) transfers glucuronic acid from UDP-glucuronic acid to a drug or drug metabolite (UDP = uridine diphosphate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

sulfation

A

SULT (Sulfotransferase) transfers sulfonate group from PAPS to a drug or drug metabolite (PAPS, 3’-
phosphoadenosine–5’-phosphosulfate)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

glutathione conjugation

A

GST (glutathione-S-transferase) attach glutathione (Glu-Cys-Gly) to a drug or drug metabolite

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Morphine P2

A

M -UGT2B7-> morphine-3-glucuronide (Major/pharm-inactive)
or
M -UGT2B7-> morphine-6-glucuronide (Minor/Pharm-active)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

NAPQI

A

(the toxic metabolite of paracetamol) - detoxification by glutathione conjugation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Outcomes of drug metabolism

A

(I) increases molecular size and hydrophilicity
(II) decreases drug elimination half-life (t1/2)
(III) alters pharmacological activity or induces toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

D.Meta outcomes
Increases molecular size and hydrophilicity

A
  • reduce tendency to accumulate
  • facilitate renal excretion
  • If drug is hydrophilic it doesn’t undergo metabolism in liver and is removed by renal excretion.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Phase 1–> functional groups
Lipophilic

A

Goes through hepatic Metabolism to make hydrophilic metabolites that go through hepatobiliary excretion to either bile or renal excretion.

21
Q

D.Meta outcomes
Decreases drug elimination half-life (t1/2) definition

A

Drug elimination half-life (t1/2) is the time taken for the drug plasma concentration to decrease by 50%
and is calculated during the elimination phase

22
Q

Plasma conc without drug metabolism

A

Has a longer half life

23
Q

Plasma conc with drug metabolism

A

Shorter half life

24
Q

D.Meta outcomes
Alters pharmacological activity or induces toxicity

A
  • Drug metabolism can terminate the action of a drug
  • Drug metabolism generates metabolites that have their own chemical properties and may be
    biologically active or inert
    parent drug
25
Q

e.g., morphine →
pharmacologically in/active

A

morphine-3-glucuronide(in)
morphine-6-glucuronide

26
Q

paracetamol →
toxic and reactive

A

NAPQI

27
Q

codeine →
pharmacologically active

A

morphine

28
Q

DMEs - cytochrome P450 (CYP)

A
  • metabolism of drugs and xenobiotics - CYP1, CYP2 and CYP3
  • 57 CYP genes in human genome
    • classified into 18 families and 43 subfamilies
29
Q

key drug metabolising CYPs

A

CYP3A4
CYP2D6

30
Q

CYPs are ___-containing proteins

A

heme

31
Q

CYPs use _____ (cofactor) and __ to metabolise xenobiotics/drugs (SH)

A

NADPH
O2
- 1 for oxidation
- 1 added to H+ to make H2O

32
Q

CYP-POR (P450 oxidoreductase) complex- electron transfer

A

NADPH
FAD
FMN
P450

33
Q

CYP450 found on ____ ____
of hepatocytes

Liver homogenates undergo sequential______ at ultra-high speed

CYP450 concentrated in_____ (formed
from ER fragments)

Used in __ ____studies to investigate drug
metabolism

A

endoplasmic reticulum (ER)

centrifugation

microsomes

in vitro

34
Q

microsomes

A

Microsomes are small sealed vesicles that originate from fragmented cell membranes (often the endoplasmic reticulum [ER]).

35
Q

Drug interaction definition

A

Process by which a substance alters the action and/or kinetics of a drug

-e.g., different CYPs have distinct but often overlapping substrate specificity

36
Q

Drug metabolism can be modified by endogenous and exogenous factors such as

A

genetics, disease
states and xenobiotics.

37
Q

CYP-mediated drug-drug interactions

A

(i) CYP induction
(ii) CYP inhibition

38
Q

CYP induction

A

drugs cause ↑ CYP expression
-rifampicin (treat tuberculosis)
- some antiepileptic drugs, e.g.,
o phenytoin
o phenobarbital*
o carbamazepine

39
Q

CYP inhibition

A

drugs compete for the active site of an enzyme when co-administered

  • a CYP inhibitor itself may or may not be a substrate for the enzyme
40
Q

Competitive Inhibition

A

substance that resembles the normal substrate competes with the substrate for the active site

41
Q

mechanism-based inhibition

A

irreversible inhibition of an enzyme due to formation of a complex between the enzyme and a reactive
metabolite via covalent bonding, e.g., ritonavir* and cobicistat*

42
Q

Outcomes of CYP inhibition

A

(a) exaggerated drug effects or toxicity due to reduced hepatic metabolism
(b) lack of drug effects due to impaired metabolic activation of prodrug

43
Q

Hepatic Metabolism

A

most drugs, once absorbed, are distributed to sites of action and then undergo metabolic changes when returned in blood through the liver.

44
Q

rifampicin is a CYP3A4_____

A

inducer

45
Q

itraconazole is a CYP3A4___

A

inhibitor

46
Q

Cobicistat

A
  • CYP3A4 inhibitor
  • no antiretroviral activity
47
Q

hepatic metabolism of alcohol

A
  • alcohol dehydrogenase (primary and saturable)
  • CYP2E1
48
Q

Alcohol and Paracetamol

A

Ethanol induces enzyme activity resulting in an increase in the metabolism of paracetamol to NAPQI